Hutch News

Hutch News

Stories tagged 'Martin Cheever'

6 questions in cancer immunotherapy

From cancer vaccines to engineered T cells, experts weigh in on the big unknowns

March 18, 2016 | by Susan Keown / Fred Hutch News Service

Fred Hutch immunotherapy experts share their perspectives on a few of the big questions in cancer immunotherapy research — and the steps that they and their colleagues are taking to answer them as quickly as they can.

View story >


Scratching the surface of a rare skin cancer

Immune-boosting therapy shows promise for advanced Merkel cell carcinoma

Oct. 6, 2015 | By Dr. Rachel Tompa / Fred Hutch News Service

Skin cancer researcher Dr. Paul Nghiem is leading a clinical trial testing the immunotherapy drug pembrolizumab for patients with advanced Merkel cell carcinoma, a rare and aggressive skin cancer. Early results from the trial are showing great promise for these patients.

View story >


What Uganda is teaching us about cancer

Fred Hutch-Uganda alliance builds a new cancer center on the shoulders of giants

May 12, 2015 | By Mary Engel / Fred Hutch News Service

"it's been a long, long journey here," said Uganda Cancer Institute physician Dr. Fred Okuku, referring to the grand opening of the UCI-Fred Hutch Cancer Centre on May 21 in Kampala.

View story >


Cancer Immunotherapy Trials Network selects member sites

Center-based initiative announces 27 institutional partners in national research effort to accelerate clinical trials of promising cancer immunotherapies

April 11, 2011

Research institutions at 27 sites across North America have been selected as part of the Cancer Immunotherapy Trials Network, based at the Fred Hutchinson Cancer Research Center. A new initiative in immunotherapy, CITN unites top academic immunologists to conduct multicenter research on therapies that boost patients’ own immune systems to fight cancer.

View story >


Center awarded $11.5 million for breast cancer research consortium

Porter, Cheever will lead the five-year Seattle-based SPORE in projects including development of targeted treatments for drug-resistant tumors

Nov. 15, 2010 | By Kristen Woodward

The National Cancer Institute has awarded $11.5 million to the Fred Hutchison Cancer Research Center to lead a five-year, Seattle-based breast cancer research consortium. The goal of the endeavor is to positively impact breast cancer prevention, detection, treatment and care of women who have or are at risk for the disease.

View story >


Immunologists’ ‘team science’ honored

Collaborative achievements in T-cell immunotherapies cited

Oct. 11, 2010

Two dozen researchers from the Fred Hutchinson/University of Washington Cancer Consortium received first-ever Team Science awards from the International Society for Biological Therapy of Cancer on Oct. 3 at the organization’s 25th annual meeting in Washington, D.C.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.